Pfizer recalls more bottles of Lipitor over odor
Pfizer announced this week that it is “recalling a lot of 19,000 bottles of the blockbuster cholesterol drug Lipitor, citing a consumer complaint about an "uncharacteristic" odor.” (NY AP, 12/21). This recall is the fourth recall since August.
The drug maker asserts that an outside manufacturer supplied the bottles, though it declined to identify the manufacturer. Pfizer also says that the health consequences are minimal. After the issue was pinpointed, Pfizer made changes back in August to address the problem. The current recall affects bottles shipped before the changes were made. The drug maker cautions that additional recalls may be necessary.
As a Chicago medical malpractice lawyer, I am hopeful that Pfizer quickly determines if any other recalls will be necessary. All patients taking Lipitor should ensure that the product is not a recalled batch before using.
Bookmark: 
